ACE Inhibitors Lower Pneumonia Threat

APRIL 01, 2005

Patients who have had a stroke can ward off the risk of pneumonia with angiotensin-converting enzyme (ACE) inhibitors. For the study, the researchers evaluated the risk of pneumonia in >1000 patients who had had a stroke. The patients involved in the 35-month study were given 1 of 3 treatments: ACE inhibitors, other blood pressure drugs, or a placebo. The data showed 2.8% of the ACE inhibitor group developed pneumonia, compared with 8.5% of the patients in the other 2 groups. (The findings were reported in Neurology, February 9, 2005.)



SHARE THIS SHARE THIS
0
Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.